More from Health & Medicine

• 
  New RSV Vaccine Slashes Infant Hospitalizations

  A new vaccine administered during pregnancy has been shown to reduce hospital admissions for infants with RSV by 80%. This breakthrough is significant as RSV causes severe respiratory illness in thousands of babies annually in the UK. With over 20,000 infants hospitalized each year, the vaccine promises to ease the burden on healthcare systems and improve infant health outcomes. Further rollout plans are expected to expand access to this protective measure.

• 
  Mother's Urgent Stem Cell Call for Sons

  Marcela Zberea is urgently seeking stem cell donors to save her two sons, Cezar (2) and David (10 months), who suffer from the rare and life-threatening Wiskott-Aldrich Syndrome. This genetic disorder severely weakens their immune systems, leaving them vulnerable and unable to live normal childhood lives. Neither parent is a donor match, prompting a public plea, especially for donors of Eastern European descent. The family, in partnership with DKMS, hopes a suitable donor will soon emerge to give the boys a chance at a normal life.

• 
  PEPFAR HIV Testing and Treatment Plunge

  New data from PEPFAR reveals a troubling drop in HIV testing and treatment rates, marking the first quantifiable impact of the Trump administration’s program shutdown and restart. This decline threatens to reverse years of progress in combating HIV globally. Experts warn urgent action is needed to restore momentum and save lives.

• 
  Revolution Medicines' Breakthrough in Pancreatic Cancer

  Revolution Medicines has reported a striking survival benefit in a Phase 3 trial for its drug daraxonrasib, doubling median survival to 13.2 months versus 6.7 months with standard chemotherapy in advanced pancreatic cancer. This breakthrough could transform treatment for a disease known for its grim prognosis. The company plans to seek FDA approval soon, potentially ushering in a new era for pancreatic cancer therapy.